Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in one rheumatological centre; two years’ drug survival

T Levälampi; M Korpela; K Vuolteenaho; E Moilanen

doi:10.1007/s00296-009-1203-1

Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in one rheumatological centre; two years’ drug survival

T Levälampi
, M Korpela
, K Vuolteenaho
, E Moilanen

Research output: Contribution to journal › Article › Scientific › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	1611-1620
Journal	Rheumatology International
Volume	30
Issue number	12
DOIs	https://doi.org/10.1007/s00296-009-1203-1
Publication status	Published - 2010
Publication type	A1 Journal article-refereed

Access to Document

10.1007/s00296-009-1203-1

Cite this

@article{2b9bd19c424649e9bc6c8f6c404684a5,

title = "Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in one rheumatological centre; two years{\textquoteright} drug survival",

author = "T Lev{\"a}lampi and M Korpela and K Vuolteenaho and E Moilanen",

year = "2010",

doi = "10.1007/s00296-009-1203-1",

language = "English",

volume = "30",

pages = "1611--1620",

journal = "Rheumatology International",

issn = "0172-8172",

publisher = "Springer",

number = "12",

}

TY - JOUR

T1 - Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in one rheumatological centre; two years’ drug survival

AU - Levälampi, T

AU - Korpela, M

AU - Vuolteenaho, K

AU - Moilanen, E

PY - 2010

Y1 - 2010

U2 - 10.1007/s00296-009-1203-1

DO - 10.1007/s00296-009-1203-1

M3 - Article

SN - 0172-8172

VL - 30

SP - 1611

EP - 1620

JO - Rheumatology International

JF - Rheumatology International

IS - 12

ER -